“The Vectron technology outperforms any previous attempt to achieve a commercially viable yield/titre of our very difficult to express therapeutic protein.
‍
The Vectron expression technology and the team have provided amazing results expressing our POI and ensured a path forward for our project.”

“When all else failed, the VB-technology worked! When we wanted to get commercially viable yields of a difficult protein, we added VB to the engineering strategy, and thereby the yield was increased more than 10-fold. We are very happy to work with Vectron and have access to their innovative and powerful technology.”

“I had a problem in the expression and the production of our protein in E. coli. In the feasibility study Vectron made every effort sincerely to find the solutions and Vectron’s technology gave higher expression titers than I expected. The results were promising and satisfactory.”

“Vectron conducted a large bioinformatics project for us which identified more than 100 unique proteins that match our application criteria, some of which were de novo designed and engineered by Vectron and many that posed very challenging manufacturing issues.
‍
Vectron then used their innovative expression technology platform to express these proteins, resulting in 18 that were produced at high titers. Vectron has delivered excellent services at a highly competitive price, and we are excited to have initiated additional projects with this highly competent company.”